CN1055405C - Mailetong capsule for promoting blood circulation - Google Patents

Mailetong capsule for promoting blood circulation Download PDF

Info

Publication number
CN1055405C
CN1055405C CN95120917A CN95120917A CN1055405C CN 1055405 C CN1055405 C CN 1055405C CN 95120917 A CN95120917 A CN 95120917A CN 95120917 A CN95120917 A CN 95120917A CN 1055405 C CN1055405 C CN 1055405C
Authority
CN
China
Prior art keywords
capsule
mailetong
blood circulation
blood
promoting blood
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN95120917A
Other languages
Chinese (zh)
Other versions
CN1151882A (en
Inventor
员殿林
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN95120917A priority Critical patent/CN1055405C/en
Publication of CN1151882A publication Critical patent/CN1151882A/en
Application granted granted Critical
Publication of CN1055405C publication Critical patent/CN1055405C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention relates to an oral Mailetong capsule which is prepared by mixing, pulverizing and encapsulating seven Chinese herbal medicines. The Mailetong capsule is characterized in that the effective rate of the Mailetong capsule for treating thromboangiitis obliterans and phlebitis reaches 100%, and the healing rate reaches more than 90%. The present invention has the advantages of convenient treatment, no pain in treatment, simple manufacture and low cost; although the Mailetong capsule has slight toxicity, the Mailetong capsule has no side effect because of few dosages.

Description

A kind of treatment thromboangiitis obliterans capsule
The present invention belongs to a kind of Chinese herbal medicine synthetics capsule.
The inflammatory disorders of a kind of peripheral vessels chronic occlusion that thromboangiitis obliterans system more easily gets involved with the middle or small artery and vein of extremity.See more in the primary disease north, mainly occurs in the male.Clinical manifestation causes the limbs ischemia by arterial disease and causes, early stage many numb at the back foot part of suffering from cold, send out cold, pain, hard expand sense, intermittent limping, symptom disappears because of blood follows improvement, but can show effect repeatedly; The state of an illness increases the weight of gradually, suffer from acroanesthesia, be afraid of cold, sharp ache, asphygmia, xerosis cutis, lossless, be pale or aubergine, fine hair come off, refer to crisp thick, the amyotrophy of (toe) first; The state of an illness continues progress can form ulcer or necrosis, and patient's General Symptoms can be more obvious.At present, treat this sick medication cloudlike, but effect is inconsiderable.
The present invention utilizes Chinese herbal medicine to grind encapsulated forming into powder.Treat this disease and get down to blood circulation promoting and blood stasis dispelling, promoting pus discharge and tissue regeneration strengthening, warming YANG and invigorating QI, reach the purpose that QI and blood is logical, venation is pacified.
Main prescription of the present invention is finished by following mode:
Hirudo 10%, Tabanus 5%, Ramulus Cinnamomi 16.7%, Evodia rutaecarpa 16.7%, the Radix Astragali 25%, the Radix Paeoniae Alba 20%, Radix Glycyrrhizae 6.6%.Above-mentioned various Chinese herbal medicine is ground into powder and is mixed encapsulated forming.
The present invention makes simply, and price is low modest, and treatment is convenient, and no pain during treatment especially to thromboangiitis obliterans, phlebitis, reaches 100% through clinical verification effective percentage for many years, and cure rate is more than 90%.
Further specify with reference to this prescription:
Theory of Chinese medical science thinks, the cold YIN pathogen that belongs to, easily impairment of YANG gas and influence the QI and blood activity.The human body deficiency, failure of defensive QI to protect the body against pathogen is close, just is subject to it is attacked by the cold and evil, so that the stasis of extremity cold coagulation, and QI and blood flows not smooth, sends out sick for this reason.Ancients' day: " general rule not bitterly, pain is then not obstructed." so with Hirudo, Tabanus blood circulation promoting and blood stasis dispelling, two medicines are slightly poisonous, act on identically, but Hirudo is the thing in the water, belongs to the yin aspect of yin, walks battalion and divides, Tabanus parasitizes the cattle body, flies in the sky, is the yang aspect of yin, walks to defend branch, two medicines share that battalion defends and, venation is living, so be monarch drug.The vim and vigour of human body are to like temperature and fear of cold, and cold then circulation gas is obstructed, and blood vessels stagnate.So with Ramulus Cinnamomi warming YANG activating QI, Fructus Evodiae specially dispel the extremity cold-evil, return the good medicine of fainting, be ministerial drug." blood is the mansion of gas, qi being the governor of blood, and the capable then blood of gas is capable, " so strengthen internal organs healthy energy with the Radix Astragali, again can promoting pus discharge and tissue regeneration strengthening, Ramulus Cinnamomi, the Radix Paeoniae Alba and Ying Wei, the Radix Glycyrrhizae coordinating the actions of various ingredients in a prescription is separated slow monarch drug toxicity.Seven flavor medicine share blood circulation promoting and blood stasis dispelling, promoting the flow of QI in the collateral by warming the meridian, QI invigorating granulation promoting, blood vessels from peace, and all diseases are double goes.
Embodiment:
Can grind encapsulated according to the given ratio of prescription above-mentioned each Chinese herbal medicine in the manufacturing process.When using this medicine, the medicine per 0.4 that is shaped can be restrained into one, every day 3 times, each 5,10 days is a course of treatment.

Claims (1)

1, a kind of treatment thromboangiitis obliterans capsule is to belong to the synthetic medicament of Chinese herbal medicine, it is characterized in that being made up of Hirudo 10%, Tabanus 5%, Ramulus Cinnamomi 16.7%, Fructus Evodiae 16.7%, the Radix Astragali 25%, the Radix Paeoniae Alba 20%, Radix Glycyrrhizae 6.6%, grinds into powder encapsulated then.
CN95120917A 1995-12-01 1995-12-01 Mailetong capsule for promoting blood circulation Expired - Fee Related CN1055405C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN95120917A CN1055405C (en) 1995-12-01 1995-12-01 Mailetong capsule for promoting blood circulation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN95120917A CN1055405C (en) 1995-12-01 1995-12-01 Mailetong capsule for promoting blood circulation

Publications (2)

Publication Number Publication Date
CN1151882A CN1151882A (en) 1997-06-18
CN1055405C true CN1055405C (en) 2000-08-16

Family

ID=5082373

Family Applications (1)

Application Number Title Priority Date Filing Date
CN95120917A Expired - Fee Related CN1055405C (en) 1995-12-01 1995-12-01 Mailetong capsule for promoting blood circulation

Country Status (1)

Country Link
CN (1) CN1055405C (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1070822A (en) * 1992-06-23 1993-04-14 余朋千 The prescription of pulse invigorating capsule and manufacture method
CN1084398A (en) * 1992-11-23 1994-03-30 李治田 Pill for supplementing qi and invigorating vasculum

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1070822A (en) * 1992-06-23 1993-04-14 余朋千 The prescription of pulse invigorating capsule and manufacture method
CN1084398A (en) * 1992-11-23 1994-03-30 李治田 Pill for supplementing qi and invigorating vasculum

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
上海中医药杂志1985(3) 1985.3.31 唐祖宣,40例血栓闭塞性脉管炎辨证疗效和微循环变化观察 *
上海中医药杂志1985(3) 1985.3.31 唐祖宣,40例血栓闭塞性脉管炎辨证疗效和微循环变化观察;中医药学报1987,(1) 1987.1.31 盖世昌,大黄虫丸治疗静脉曲张并发症与后遗症的探讨 *
中医药学报1987,(1) 1987.1.31 盖世昌,大黄虫丸治疗静脉曲张并发症与后遗症的探讨 *

Also Published As

Publication number Publication date
CN1151882A (en) 1997-06-18

Similar Documents

Publication Publication Date Title
CN100548350C (en) A kind of Chinese medicine for the treatment of thromboangiitis obliterans
CN101391077B (en) Preparation method of traditional Chinese medicine for treating chronic pelvic inflammatory disease
CN102188678A (en) Method for preparing Chinese medicine for treating frostbite due to deficiency of clothes
CN104667047B (en) A kind of herb liquid for treating diabetes
CN106266896A (en) A kind of invigorating primordial QI, kidney invigorating and YANG supporting, bone and muscle strengthening, the pill of curing rheumatism
CN102793904B (en) Preparation method for traditional Chinese medicine lotion for treatment of confusing-type closed fracture
CN1055405C (en) Mailetong capsule for promoting blood circulation
CN102813881B (en) Preparation method of traditional Chinese medicine for treating abdominal distension type acute glomerulonephritis
CN103041226B (en) Traditional Chinese medicine for treating effusion of knee joint
CN101195002B (en) Chinese medicine emplastrum for releasing ache and health care
CN103211911A (en) Medicine for treating thromboangiitis obliterans
CN102631549B (en) Preparation method of traditional Chinese medicine lotion for treating acute lymphangitis
CN102813822B (en) Preparation method of traditional Chinese medicine for treating pain type acute glomerulonephritis
CN103127283A (en) Medicine for treating pelvic inflammation
CN107596028A (en) It is a kind of to treat apoplexy, the Chinese medicine composition of cerebral infarction
CN102824421A (en) Method for preparing Chinese medicinal lotion for treating surprised type closed fracture
CN102813880B (en) A kind of Chinese medicinal preparation method for the treatment of blood stasis type acute glomerulonephritis
CN102764374A (en) Chinese medicine powder for treating peptic ulcer
CN102631633B (en) Preparation method for traditional Chinese medicine wash lotion for treating constipation type acute lymphangitis
CN106110215A (en) A kind of medicine treating varicose veins of the lower extremity
CN100337652C (en) Chinese medicinal decoction for preventing and treating cancer
CN103948804B (en) A kind of Chinese medicine composition treating lung qi deficiency dermatitis aestivale
CN103800621A (en) Traditional Chinese medicine composition for treating prostatic hyperplasia and prostatitis
CN102824621B (en) Method for preparing Chinese medicinal lotion for treating over-fatigue type closed fracture
CN103272035B (en) Sphacelus treatment medicine

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee